Ribometrix
PrivateLast Round
Strategic
Jan 6, 2021
Total Funding Raised
$45.79M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ribometrix is a biotechnology company that develops small molecule therapeutics designed to modulate RNA biology for the treatment of human diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ribometrix Comparables
Compare Ribometrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arrakis Therapeutics | 93% | |
| Expansion Therapeutics | 90% | |
| Base4 Biotechnology | 89% | |
Ribometrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 6, 2021 | ||||
| Strategic | Sep 30, 2019 | ||||
| Series A Extension | Sep 27, 2019 | ||||
| Series A | Nov 13, 2018 | ||||
| Seed | Oct 31, 2017 |
Key People
Founding team and executive leadership
Ribometrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A, Series A Extension, Seed |
| A. M. Pappas & Associates | Series A |
| MP Healthcare Venture Management | Seed, Series A |
| NIH RADx | Grant |
| Genentech | Strategic |
| M Ventures | Series A |
| Hatteras Venture Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 81% MoM.
- Jan 9, 2025
Katie Warner appointed as new Chief Scientific Officer.
Ribometrix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ribometrix's valuation, stock price, and market status.